7-Methylhexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one
Common Name: |
7-Methylhexahydro-2H-benzo[b][1,4]dioxepin-3(4H)-one |
IUPAC Name: |
7-methyl-5a,6,7,8,9,9a-hexahydrobenzo[b][1,4]dioxepin-3-one |
Molecular Formula: |
C10H16O3 |
SMILES: |
CC1CCC2C(C1)OCC(=O)CO2 |
Inchi: |
1S/C10H16O3/c1-7-2-3-9-10(4-7)13-6-8(11)5-12-9/h7,9-10H,2-6H2,1H3 |
Inchi Key: |
LTSMPUUMDMERTD-UHFFFAOYSA-N |
Cas No: |
1217714-24-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
184.23 |
Mass (g/mol) |
184.11 |
Molar Refractivity |
48.33 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
0 |
Rings |
2 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
1.16 |
iLOGP |
2.27 |
XLOGP3 |
1.35 |
WLOGP |
1.16 |
MLOGP |
0.50 |
ESOL Log S |
-1.83 |
ESOL Solubility (mg/ml) |
2.71 |
ESOL Solubility (mol/l) |
0.015 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.70 |
Ali Solubility (mg/ml) |
3.69 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.44 |
Silicos-IT Solubility (mg/ml) |
6.64 |
Silicos-IT Solubility (mol/l) |
0.04 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.47 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.256 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.939 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |